We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIR.L Regulatory News (CIR)

  • There is currently no data for CIR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Apr 2020 07:30

RNS Number : 5304J
Circassia Pharmaceuticals Plc
14 April 2020
 

Director/PDMR Shareholding

Oxford, UK - 14 April 2020: Circassia Pharmaceuticals plc ("Circassia" or "the Company"; LSE: CIR), a specialty biopharmaceutical company focused on respiratory disease, today announces that on 9 April 2020, Ian Johnson, Executive Chairman of Circassia purchased 200,000 Ordinary Shares at a price of 22.85 pence per share, Michael Roller, Chief Financial Officer purchased 200,000 Ordinary Shares at a price of 22.683 pence per share and Jonathan Emms, Chief Operating Officer of Circassia, purchased 300,000 Ordinary Shares at a price of 23.2 pence per share.

Following these purchases, Ian Johnson holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company), Michael Roller holds 200,000 Ordinary Shares (0.05% of the issued share capital of the Company) and Jonathan Emms holds 600,000 Ordinary Shares (0.16% of the issued share capital of the Company).

Contacts

Circassia Pharmaceuticals plc

Ian Johnson Executive Chairman

Michael Roller Chief Financial Officer

c/o FTI Consulting

 

 

Peel Hunt LLP (Nominated Adviser and Broker)

James Steel / Oliver Jackson

 

Tel: +44 (0)20 7418 8900

finnCap (Joint Broker)

Geoff Nash / Alice Lane

 

Tel: +44 (0) 20 7220 0500

Numis Securities (Joint Broker)

James Black / Duncan Monteith

 

Tel: +44 (0) 20 7260 1000

FTI Consulting

Simon Conway / Ciara Martin

Tel: +44 (0) 20 3727 1000

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Ian Johnson

2. Michael Roller

3. Jonathan Emms

2.

Reason for the notification

a.

Position/status

1. Executive Chairman

2. Chief Financial Officer

3. Chief Operating Officer

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Circassia Pharmaceuticals plc

b.

LEI

2138006YAT138TOGA556

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary Shares of 0.08p each

 

 

GB00BJVD3B28

b.

Nature of the transaction

Purchase of Ordinary Shares

 

c.

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

1. 22.85p

2. 22.683p

3. 23.2p

1. 200,000

2. 200,000

3. 300,000

d.

Aggregated information

· Aggregated volume

· Price

 

 

 

n/a

 

e.

Date of the transaction

2020-04-09

f.

Place of the transaction

London Stock Exchange, AIM

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHGLGDSCDBDGGS
Date   Source Headline
24th Mar 20217:00 amRNSPreliminary Results
4th Feb 20218:30 amRNSPDMR Dealing - Transfer for Nil Consideration
29th Jan 20214:45 pmRNSTotal Voting Rights
12th Jan 20217:01 amRNSTrading Update
12th Jan 20217:00 amRNSChange of Nominated Adviser and Broker
31st Dec 20207:00 amRNSTotal Voting Rights
30th Nov 202012:34 pmRNSTotal Voting Rights
13th Nov 20207:00 amRNSBoard Appointment
10th Nov 20205:14 pmRNSChange of Registered Office
30th Oct 20207:00 amRNSTotal Voting Rights
2nd Oct 202011:19 amRNSHolding(s) in Company
30th Sep 20207:00 amRNSBlock listing Interim Review
30th Sep 20207:00 amRNSTotal Voting Rights
24th Sep 20203:14 pmRNSHolding(s) in Company
17th Sep 20207:00 amRNSInterim Results - Ended 30 June 2020
1st Sep 20207:00 amRNSGrant of Options
28th Aug 20207:00 amRNSTotal Voting Rights
21st Aug 202011:16 amRNSHolding(s) in Company
14th Aug 20207:00 amRNSGrant of options
10th Aug 202011:49 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSTotal Voting Rights Update
23rd Jul 202010:52 amRNSResult of AGM
30th Jun 20207:00 amRNSTotal Voting Rights
17th Jun 202010:23 amRNSAnnual report and notice of AGM
16th Jun 20207:00 amRNSPreliminary Results
8th Jun 20201:12 pmRNSHolding(s) in Company
8th Jun 202011:42 amRNSHolding(s) in Company
2nd Jun 20207:00 amRNSEquity Financing Facility
29th May 20207:00 amRNSTotal Voting Rights
28th May 20207:00 amRNSCompletion of Transaction
27th May 20207:00 amRNSFurther re Transfer of Assets
18th May 20201:23 pmRNSBlock Listing Application
1st May 202011:12 amRNSGrant of options
1st May 202011:04 amRNSTotal Voting Rights
1st May 202010:32 amRNSChange of Name Effective
30th Apr 202010:34 amRNSResult of General Meeting
27th Apr 20204:27 pmRNSIssue of Equity
24th Apr 20203:58 pmRNSHolding(s) in Company
24th Apr 202012:32 pmRNSHolding(s) in Company
15th Apr 20202:13 pmRNSHolding(s) in Company
15th Apr 20207:00 amRNSPosting of circular and update on undertakings
14th Apr 20204:37 pmRNSHolding(s) in Company
14th Apr 20207:30 amRNSDirector/PDMR Shareholding
9th Apr 20207:00 amRNSProposed transfer of assets
31st Mar 20207:00 amRNSBlock listing Interim Review
31st Mar 20207:00 amRNSTotal Voting Rights
28th Feb 20207:03 amRNSFurther re Board appointment
28th Feb 20207:00 amRNSTotal Voting Rights
17th Feb 20202:17 pmRNSHolding(s) in Company
31st Jan 20207:00 amRNSTotal Voting Rights Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.